ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Louisiana » Interventional Pain Medicine

Top Interventional Pain Medicine Prescribers in Louisiana

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
ARNOLD FELDMAN M.D.

Interventional Pain Medicine

15,219

$905K

537
150 are 65+

64%
patients receiving schedule two controlled substances

Avg: 29%

60%
patients receiving schedule three controlled substances

Avg: 43%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 5%

13%
prescriptions for brand name drugs

Avg: 15%

$59
Average prescription price

Avg: $62

JOHN LEDBETTER M.D.

Interventional Pain Medicine

8,916

$481K

962
628 are 65+

33%
patients receiving schedule two controlled substances

Avg: 29%

54%
patients receiving schedule three controlled substances

Avg: 43%

6%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 5%

14%
prescriptions for brand name drugs

Avg: 15%

$54
Average prescription price

Avg: $62

TARUN JOLLY MD

Interventional Pain Medicine

8,649

$391K

1220
510 are 65+

31%
patients receiving schedule two controlled substances

Avg: 29%

59%
patients receiving schedule three controlled substances

Avg: 43%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 5%

8%
prescriptions for brand name drugs

Avg: 15%

$45
Average prescription price

Avg: $62

VINCENT FORTE M.D.

Interventional Pain Medicine

8,164

$435K

769
476 are 65+

27%
patients receiving schedule two controlled substances

Avg: 29%

50%
patients receiving schedule three controlled substances

Avg: 43%

8%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 5%

15%
prescriptions for brand name drugs

Avg: 15%

$53
Average prescription price

Avg: $62

CHAD DOMANGUE MD

Interventional Pain Medicine

6,356

$544K

639
312 are 65+

45%
patients receiving schedule two controlled substances

Avg: 29%

40%
patients receiving schedule three controlled substances

Avg: 43%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 5%

13%
prescriptions for brand name drugs

Avg: 15%

$86
Average prescription price

Avg: $62

J BURDINE MD

Interventional Pain Medicine

6,086

$393K

711
359 are 65+

37%
patients receiving schedule two controlled substances

Avg: 29%

49%
patients receiving schedule three controlled substances

Avg: 43%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 5%

12%
prescriptions for brand name drugs

Avg: 15%

$65
Average prescription price

Avg: $62

JONATHAN THOMPSON M.D.

Interventional Pain Medicine

5,864

$325K

638
348 are 65+

33%
patients receiving schedule two controlled substances

Avg: 29%

60%
patients receiving schedule three controlled substances

Avg: 43%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 5%

7%
prescriptions for brand name drugs

Avg: 15%

$55
Average prescription price

Avg: $62

JOHN BRASWELL M.D.

Interventional Pain Medicine

5,282

$403K

536
245 are 65+

43%
patients receiving schedule two controlled substances

Avg: 29%

56%
patients receiving schedule three controlled substances

Avg: 43%

6%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 5%

13%
prescriptions for brand name drugs

Avg: 15%

$76
Average prescription price

Avg: $62

RONALD SEGURA MD

Interventional Pain Medicine

4,975

$558K

507
214 are 65+

59%
patients receiving schedule two controlled substances

Avg: 29%

43%
patients receiving schedule three controlled substances

Avg: 43%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 5%

20%
prescriptions for brand name drugs

Avg: 15%

$112
Average prescription price

Avg: $62

JOSEPH TURNIPSEED M.D.

Interventional Pain Medicine

4,973

$287K

516
246 are 65+

33%
patients receiving schedule two controlled substances

Avg: 29%

62%
patients receiving schedule three controlled substances

Avg: 43%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 5%

11%
prescriptions for brand name drugs

Avg: 15%

$58
Average prescription price

Avg: $62

SEAN GRAHAM M.D.

Interventional Pain Medicine

4,852

$307K

650
330 are 65+

42%
patients receiving schedule two controlled substances

Avg: 29%

45%
patients receiving schedule three controlled substances

Avg: 43%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 5%

13%
prescriptions for brand name drugs

Avg: 15%

$63
Average prescription price

Avg: $62

MARK DENNIS M.D.

Interventional Pain Medicine

4,673

$352K

305
176 are 65+

38%
patients receiving schedule two controlled substances

Avg: 29%

55%
patients receiving schedule three controlled substances

Avg: 43%

6%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 5%

22%
prescriptions for brand name drugs

Avg: 15%

$75
Average prescription price

Avg: $62

PETER ZIMMERMAN MD

Interventional Pain Medicine

4,107

$144K

245
98 are 65+

35%
patients receiving schedule two controlled substances

Avg: 29%

73%
patients receiving schedule three controlled substances

Avg: 43%

6%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 5%

12%
prescriptions for brand name drugs

Avg: 15%

$35
Average prescription price

Avg: $62

JEFFEREY ADAIR MD

Interventional Pain Medicine

3,616

$199K

327
156 are 65+

48%
patients receiving schedule two controlled substances

Avg: 29%

58%
patients receiving schedule three controlled substances

Avg: 43%

6%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 5%

12%
prescriptions for brand name drugs

Avg: 15%

$55
Average prescription price

Avg: $62

PATRICK WARING MD

Interventional Pain Medicine

2,703

$79.8K

663
548 are 65+

23%
patients receiving schedule two controlled substances

Avg: 29%

49%
patients receiving schedule three controlled substances

Avg: 43%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 5%

11%
prescriptions for brand name drugs

Avg: 15%

$30
Average prescription price

Avg: $62

JIHAD JIHA M.D.

Interventional Pain Medicine

2,496

$171K

362
238 are 65+

26%
patients receiving schedule two controlled substances

Avg: 29%

46%
patients receiving schedule three controlled substances

Avg: 43%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 5%

15%
prescriptions for brand name drugs

Avg: 15%

$69
Average prescription price

Avg: $62

STEVE WYBLE M.D.

Interventional Pain Medicine

2,200

$113K

178
128 are 65+

35%
patients receiving schedule two controlled substances

Avg: 29%

47%
patients receiving schedule three controlled substances

Avg: 43%

8%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 5%

13%
prescriptions for brand name drugs

Avg: 15%

$51
Average prescription price

Avg: $62

CAROLINE BARTON MD

Interventional Pain Medicine

2,115

$213K

185
105 are 65+

10%
patients receiving schedule two controlled substances

Avg: 29%

8%
patients receiving schedule three controlled substances

Avg: 43%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 5%

20%
prescriptions for brand name drugs

Avg: 15%

$101
Average prescription price

Avg: $62

KEVIN MARTINEZ M.D.

Interventional Pain Medicine

2,108

$162K

219
156 are 65+

31%
patients receiving schedule two controlled substances

Avg: 29%

42%
patients receiving schedule three controlled substances

Avg: 43%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 5%

20%
prescriptions for brand name drugs

Avg: 15%

$77
Average prescription price

Avg: $62

JOSEPH CRAPANZANO M.D.

Interventional Pain Medicine

1,928

$146K

237
176 are 65+

15%
patients receiving schedule two controlled substances

Avg: 29%

33%
patients receiving schedule three controlled substances

Avg: 43%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 5%

27%
prescriptions for brand name drugs

Avg: 15%

$76
Average prescription price

Avg: $62

JIMMY PONDER MD

Interventional Pain Medicine

1,499

$50K

369
215 are 65+

0%
patients receiving schedule two controlled substances

Avg: 29%

0%
patients receiving schedule three controlled substances

Avg: 43%

10%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 5%

13%
prescriptions for brand name drugs

Avg: 15%

$33
Average prescription price

Avg: $62

ERIC LONSETH M.D

Interventional Pain Medicine

1,422

$106K

229
152 are 65+

9%
patients receiving schedule two controlled substances

Avg: 29%

28%
patients receiving schedule three controlled substances

Avg: 43%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 5%

26%
prescriptions for brand name drugs

Avg: 15%

$75
Average prescription price

Avg: $62

ADOLFO CUADRA MD

Interventional Pain Medicine

1,344

$37.1K

365
193 are 65+

0%
patients receiving schedule two controlled substances

Avg: 29%

0%
patients receiving schedule three controlled substances

Avg: 43%

10%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 5%

13%
prescriptions for brand name drugs

Avg: 15%

$28
Average prescription price

Avg: $62

LUIS HERNANDEZ M.D.

Interventional Pain Medicine

777

$57.1K

130
87 are 65+

12%
patients receiving schedule two controlled substances

Avg: 29%

32%
patients receiving schedule three controlled substances

Avg: 43%

7%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 5%

17%
prescriptions for brand name drugs

Avg: 15%

$73
Average prescription price

Avg: $62

WILLIAM WHYTE M.D.

Interventional Pain Medicine

386

$14.4K

90
72 are 65+

0%
patients receiving schedule two controlled substances

Avg: 29%

19%
patients receiving schedule three controlled substances

Avg: 43%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 5%

8%
prescriptions for brand name drugs

Avg: 15%

$37
Average prescription price

Avg: $62

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank